Revolut has reached a landmark €65 billion ($75 billion) valuation after a significant secondary share sale, marking one of the largest private-market valuations ever achieved by a European tech company.
Revolut has reached a landmark €65 billion ($75 billion) valuation after a significant secondary share sale, marking one of the largest private-market valuations ever achieved by a European tech company.
Bristol-based biomaterials startup Ponda has secured €2.09 million in Seed funding to accelerate commercialisation of its plant-based insulation material, BioPuff.
Numeric — the AI-powered accounting automation company with teams in San Francisco, New York, and London — has secured $51 million in Series B funding, bringing total capital raised to $89 million.
UK-based Vyntelligence has raised $30 million in Series B funding to scale its AI-powered video intelligence platform, with a strong focus on expanding operations in the United States.
Financial automation startup Dost has entered the UK market after closing a £6 million Series A round led by Octopus Ventures, marking the company’s biggest expansion since its founding.
When the COVID lockdowns hit, Emm founder Jenny Button noticed a gap. Devices like Oura and Whoop could track sleep, stress, and recovery — but nothing offered meaningful insights into one of the most fundamental aspects of women’s health: the menstrual cycle. “It seemed crazy to me,” she told TechCrunch.
European life sciences venture capital firm Medicxi has closed Medicxi V, a €500 million fund dedicated to backing biotech companies with clear product visions and a focus on improving patient care.
Sofinnova Partners, one of Europe’s leading life sciences venture capital firms, has closed Sofinnova Capital XI at €650 million ($750 million) — well above its initial target.
